Richmond, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to a research report "Tissue Engineering Market”, by Material Type (Synthetic Scaffold Material, Biological Derived Scaffold, Others), Application (Orthopaedics & Muscoskeleton, Neurology, Cardiovascular, Skin & Integumentary, Dental, Others), End User (Hospitals & Clinics, Ambulatory Facilities, Healthcare & Medical Institutes, Others) and Region - Global Forecast to 2030.
Global Tissue Engineering Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 13.3 Billion |
| Market size value in 2030 | USD 27.6 Billion |
| CAGR (2023-2030) | 11.0% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Material Type, Application, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3793
TOC Covers in Depth & Breath on Tissue Engineering Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Material Type Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Material Type Biological Derived Scaffold, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The Global Tissue Engineering Market has emerged as an innovation to emerge in the automobile sector and others. Tissue engineering is a dynamic and evolving field within the biomedical sector, characterized by the convergence of biology, engineering, and materials science to develop functional substitutes for damaged or diseased tissues. One of prominent factors propelling the growth of the tissue engineering market is the escalating demand for viable solutions to address organ and tissue shortages. As the global population ages and the incidence of chronic diseases rises, there is an increasing need for innovative approaches to regenerate and repair damaged tissues and organs.
Tissue engineering offers the promise of creating artificial tissues and organs that can integrate seamlessly with the host's biological systems, presenting a transformative solution for patients awaiting transplants or suffering from debilitating conditions. This imperative to provide effective therapeutic alternatives has spurred investments in research and development, fostering advancements in tissue engineering technologies and contributing to the expansion of this pivotal healthcare domain.
Major Vendors in the Global Tissue Engineering Market:
- AbbVie (Allergan)
- ACell, Inc.
- Athersys, Inc.
- B. Braun
- Baxter International, Inc.
- Becton Dickinson and Company
- Integra LifeSciences Corporation
- Medtronic
- Organogenesis Holdings Inc.
- ReproCell, Inc.
- RTI Surgical, Inc.
- Stryker Corporation
- Tissue Regenix Group plc
- Zimmer Biomet Holdings, Inc.
Request for Discount @ https://www.marketdigits.com/request/discount/3793
Technical advancements with regards to medical applications
Continuous progress in regenerative medicine technologies propels the tissue engineering market forward. Persistent research and development endeavors have refined bio fabrication techniques, biomaterials, and cellular therapies. These technological advancements improve the precision and effectiveness of tissue engineering processes, facilitating the development of intricate and functional tissues for diverse medical applications. The dynamic evolution of regenerative medicine significantly contributes to the market's expansion by broadening the possibilities and feasibility of tissue engineering solutions.
The steep increase in the aging population globally has led to the increased demand for the organ and tissue transplants. A key catalyst for the tissue engineering market is the increasing need for viable substitutes to conventional organ transplants. Given the aging global demographic and a growing prevalence of organ failure, tissue engineering presents an innovative strategy to alleviate the scarcity of donor organs. The imperative to generate functional and compatible tissues through regenerative methods has become essential in fulfilling the rising demand for critical transplant procedures, thereby in a transformative era in healthcare.
Market Dynamics
Drivers:
- Organ Shortage Mitigation
- Rising Prevalence of Chronic Diseases
- Demand for Personalized Medicine:
- Governmental Support and Funding from the private players.
- Expanded applications in different medical fields.
Opportunities:
- Advanced Biomaterial Development.
- Personalized Medicine Integration.
- Expanded Veterinary Applications
- Collaboration with Pharmaceutical Companies
- 3D Bioprinting Technology and Stemcell Therapy advancements.
Advancements in Tissue Engineering Material
The primary objective of tissue engineering in the context of personalized medicine is to develop biomaterials that can seamlessly integrate with the patient's biological systems, promoting optimal tissue regeneration and function. These materials must possess key attributes such as biocompatibility, bioactivity, and mechanical properties that mimic natural tissues. By selecting or engineering materials that closely resemble the patient's own tissues, the risk of rejection is minimized, and the potential for successful integration and long-term functionality is maximized.
One of the key advancements in tissue engineering materials for personalized medicine is the development of bioactive scaffolds. These scaffolds act as a three-dimensional framework, providing structural support for cell attachment, proliferation, and differentiation. Incorporating bioactive molecules into these scaffolds further enhances their functionality by promoting specific cellular responses, guiding tissue development, and accelerating the healing process.
North America dominates the market for Tissue Engineering Material.
North America led the market with the highest revenue. This is because more people are becoming aware of stem cell therapy, and the number of older individuals and those with chronic diseases are increasing. Additionally, the region has advanced technology for diagnosing and treating chronic illnesses, plenty of funding from private and government sources, and a high amount of spending on healthcare, all contributing to its large share.
The growth of the market was also driven by improvements in 3D tissue engineering technology, and the presence of well-known companies continuously launching new products. For instance, in April 2022, Organogenesis, a major player in regenerative medicine, shared their latest progress in wound care research at a conference in Phoenix, Arizona. They highlighted products like PuraPly AM, Affinity, Apligraf, and Organogenesis Physician Solutions.
The Asia Pacific market is expected to experience the significant growth in Compound Annual Growth Rate (CAGR) in the forecast period. Japan stands out as a leading country driving technological advancements in tissue engineering. Moreover, the rising occurrence of clinical disorders, including cancer, across Asian nations, combined with the development of 3D bioprinting and the growth of medical facilities, is anticipated to boost market expansion in this geographical area.
The Application Segment is anticipated to hold the Largest Market Share during the Forecast Period
In the global Tissue Engineering Market the application segment is categorized into Orthpaedics & Muscoskeleton, Neurology, Cardiovascular, Skin & Integumentary, Others. Regarding its use, the part of tissue engineering related to orthopedics, musculoskeletal issues, and spine conditions was the most profitable, holding a significant share. This is mainly because more people are dealing with musculoskeletal disorders. Tissue engineering has become a crucial option for orthopedic surgeons treating various musculoskeletal problems, from issues in young athletes' meniscus to abnormalities in the glenohumeral joint. According to the World Health Organization (WHO), over 23 million people worldwide are affected by rheumatoid arthritis The growth of this segment is expected due to different strategies adopted by market players and the introduction of new products and its continuous development.
The cardiology and vascular segment are projected to have the highest Compound Annual Growth Rate (CAGR) over the forecast period. This is attributed to the increasing prevalence of cardiovascular issues. Significant players in the industry are actively working on developing stem cell therapies to repair and restore damaged heart tissues. Moreover, research is underway on gene therapy, advanced biologics, and small molecules to encourage the regeneration of damaged heart cells.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3793
Browse Similar Reports:
Frozen Tissues Samples Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Tissue Sealants and Tissue Adhesive Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Absorbable Tissue Spacer Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
